|
|
40
|
|
|
A101L
|
|
|
LABETALOL 5MG/ML INJ (MON/PHA)
|
|
|
LABETALOL
|
|
|
LABETALOL
|
|
|
20ML
|
|
|
B
|
|
|
8.67
|
|
|
8.67
|
|
|
5MG/ML
|
|
|
INJECTION
|
|
|
0
|
|
|
VIAL
|
|
|
MON
|
|
|
MONTAGE PHARMACEUTICALS
|
|
|
PHA
|
|
|
PHARMACY SALES CARIBBEAN
|
|
|
|
|
|
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
No
|
|
|
2424
|
|
|
BETA ADRENERGIC BLOCKING AGENTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
CARDIOVASCULAR DRUGS
|
|
|
|